X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15616) 15616
Book Review (2024) 2024
Publication (1164) 1164
Book Chapter (158) 158
Conference Proceeding (107) 107
Dissertation (22) 22
Book / eBook (7) 7
Magazine Article (5) 5
Web Resource (5) 5
Newspaper Article (4) 4
Data Set (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10776) 10776
humans (10321) 10321
cholangiocarcinoma (7879) 7879
male (6480) 6480
female (6003) 6003
middle aged (5488) 5488
aged (4883) 4883
adult (3483) 3483
cholangiocarcinoma - pathology (3418) 3418
surgery (3400) 3400
gastroenterology & hepatology (3381) 3381
bile duct neoplasms - pathology (3254) 3254
cancer (3006) 3006
oncology (3001) 3001
intrahepatic cholangiocarcinoma (2555) 2555
bile ducts, intrahepatic (2453) 2453
cholangiocarcinoma - surgery (2264) 2264
liver (2245) 2245
bile duct neoplasms - surgery (2208) 2208
prognosis (2154) 2154
aged, 80 and over (1976) 1976
retrospective studies (1770) 1770
bile ducts, intrahepatic - pathology (1682) 1682
hilar cholangiocarcinoma (1675) 1675
carcinoma (1630) 1630
treatment outcome (1603) 1603
cholangiocarcinoma - diagnosis (1535) 1535
animals (1464) 1464
tumors (1459) 1459
hepatocellular-carcinoma (1425) 1425
bile duct neoplasms - diagnosis (1375) 1375
survival (1373) 1373
medicine & public health (1339) 1339
liver neoplasms - pathology (1264) 1264
diagnosis (1236) 1236
expression (1219) 1219
abridged index medicus (1210) 1210
hepatectomy (1206) 1206
bile duct neoplasms - mortality (1188) 1188
cholangiocarcinoma - mortality (1158) 1158
immunohistochemistry (1157) 1157
hepatocellular carcinoma (1146) 1146
metastasis (1089) 1089
cholangiocarcinoma - metabolism (1088) 1088
chemotherapy (1076) 1076
pathology (1074) 1074
radiology, nuclear medicine & medical imaging (1061) 1061
risk factors (1051) 1051
analysis (1035) 1035
management (1010) 1010
survival rate (982) 982
liver cancer (950) 950
cholangiocarcinoma - genetics (906) 906
neoplasm staging (900) 900
bile duct neoplasms - metabolism (896) 896
diagnosis, differential (880) 880
cell line, tumor (874) 874
resection (864) 864
primary sclerosing cholangitis (845) 845
liver neoplasms - surgery (826) 826
cholangiocarcinoma - diagnostic imaging (823) 823
gastroenterology (800) 800
follow-up studies (785) 785
tomography, x-ray computed (781) 781
bile (764) 764
carcinoma, hepatocellular - pathology (760) 760
cholangiocarcinoma - therapy (759) 759
cholangiocarcinoma - drug therapy (753) 753
apoptosis (744) 744
bile duct neoplasms - genetics (735) 735
health aspects (726) 726
bile duct neoplasms - therapy (719) 719
bile duct neoplasms - diagnostic imaging (703) 703
bile ducts, intrahepatic - surgery (691) 691
survival analysis (681) 681
research (654) 654
cholangiocarcinoma - complications (651) 651
patients (632) 632
medical prognosis (621) 621
magnetic resonance imaging (620) 620
mortality (620) 620
bile duct neoplasms - complications (616) 616
liver transplantation (602) 602
gastroenterology and hepatology (599) 599
bile duct neoplasms - drug therapy (598) 598
mice (578) 578
hepatectomy - methods (576) 576
time factors (576) 576
proteins (553) 553
liver - pathology (545) 545
hepatology (542) 542
liver neoplasms - diagnosis (532) 532
gemcitabine (529) 529
liver neoplasms - secondary (526) 526
neoplasm invasiveness (518) 518
sensitivity and specificity (494) 494
risk-factors (492) 492
article (488) 488
gene expression (488) 488
kaplan-meier estimate (485) 485
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14005) 14005
Korean (388) 388
German (386) 386
Japanese (384) 384
French (216) 216
Chinese (172) 172
Spanish (135) 135
Italian (53) 53
Russian (41) 41
Polish (19) 19
Portuguese (14) 14
Romanian (9) 9
Czech (8) 8
Danish (8) 8
Dutch (5) 5
Hungarian (5) 5
Turkish (4) 4
Hebrew (3) 3
Bulgarian (2) 2
Finnish (2) 2
Serbian (2) 2
Croatian (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Slovak (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


HPB, ISSN 1365-182X, 2008, Volume 10, Issue 2, pp. 77 - 82
Journal Article
Modern Pathology, ISSN 0893-3952, 2014, Volume 27, Issue 8, pp. 1163 - 1173
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 142, Issue 4, pp. 1021 - 1031.e15
Background & Aims Cholangiocarcinoma is a heterogeneous disease with a poor outcome that accounts for 5%−10% of primary liver cancers. We characterized its... 
Gastroenterology and Hepatology | CCA | Gene Expression | Hepatic | Genetic Analysis | SURVIVAL | INTRAHEPATIC CHOLANGIOCARCINOMA | PHASE-II | RECEPTOR | EXPRESSION PROFILES | BREAST-CANCER | BILIARY CANCER | LUNG-CANCER | HEPATOCELLULAR-CARCINOMA | MUTATIONS | GASTROENTEROLOGY & HEPATOLOGY | Immunohistochemistry | Receptor, Epidermal Growth Factor - genetics | Proto-Oncogene Proteins p21(ras) | Oligonucleotide Array Sequence Analysis | Humans | Middle Aged | Tumor Microenvironment | Male | Bile Duct Neoplasms - enzymology | Time Factors | Bile Duct Neoplasms - genetics | Cholangiocarcinoma - enzymology | Precision Medicine | Genetic Predisposition to Disease | Risk Assessment | Risk Factors | ras Proteins - antagonists & inhibitors | Survival Rate | Blotting, Western | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Phenotype | Belgium | Cell Line, Tumor | Cholangiocarcinoma - genetics | Mutation | Quinazolines - pharmacology | Trastuzumab | Cluster Analysis | Protein-Tyrosine Kinases - antagonists & inhibitors | ras Proteins - genetics | Prognosis | United States | Laser Capture Microdissection | Molecular Targeted Therapy | Patient Selection | Protein-Tyrosine Kinases - genetics | Antibodies, Monoclonal, Humanized - pharmacology | Female | Antineoplastic Agents - pharmacology | Bile Duct Neoplasms - drug therapy | Proto-Oncogene Proteins - antagonists & inhibitors | Bile Ducts, Intrahepatic - pathology | Cholangiocarcinoma - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Gene Expression Profiling - methods | Proto-Oncogene Proteins - genetics | Chi-Square Distribution | Bile Ducts, Intrahepatic - enzymology | Cholangiocarcinoma - pathology | Cholangiocarcinoma - drug therapy | Proto-Oncogene Proteins B-raf - genetics | Bile Duct Neoplasms - mortality | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Bile Duct Neoplasms - pathology | Protein-Tyrosine Kinases - analysis | Queensland | Tyrosine | Genes | Amino acids | Transforming growth factors | Gene expression | Liver cancer | Epidermal growth factor | Analysis | Phenols | Genetic research | Genetic aspects | Health aspects | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Magnetic Resonance Imaging, ISSN 1053-1807, 07/2017, Volume 46, Issue 1, pp. 267 - 280
PurposeTo evaluate gadoxetic acid-enhanced magnetic resonance imaging (MRI) findings of combined hepatocellular cholangiocarcinoma (cHCC-CC) with special... 
2010 WHO classification | combined hepatocellular‐cholangiocarcinoma | gadoxetic acid‐enhanced MRI | gadoxetic acid-enhanced MRI | combined hepatocellular-cholangiocarcinoma | INTRAHEPATIC CHOLANGIOCARCINOMA | LI-RADS | HEPATECTOMY | LIVER-CARCINOMA | TRANSPLANTATION | CLINICOPATHOLOGICAL CHARACTERISTICS | CARCINOMA-CHOLANGIOCARCINOMA | IMAGING FEATURES | HEPATOBILIARY AGENTS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Hepatocellular - mortality | Prevalence | Prognosis | Humans | Middle Aged | Male | Statistics as Topic | Neoplasms, Multiple Primary - diagnostic imaging | Liver Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Carcinoma, Hepatocellular - diagnostic imaging | Neoplasm Recurrence, Local - diagnostic imaging | Magnetic Resonance Imaging - statistics & numerical data | Aged, 80 and over | Adult | Female | Liver Neoplasms - pathology | Republic of Korea - epidemiology | Neoplasms, Multiple Primary - mortality | Risk Factors | Cholangiocarcinoma - mortality | Survival Rate | Neoplasms, Multiple Primary - pathology | Liver Neoplasms - diagnostic imaging | Cholangiocarcinoma - pathology | Cholangiocarcinoma - diagnostic imaging | Contrast Media | Carcinoma, Hepatocellular - pathology | Aged | Gadolinium DTPA | Magnetic resonance imaging | Public health | Stem cells | Correlation | Nuclear magnetic resonance--NMR | Liver | Stroma | Survival | Acids | Surgery | Medical prognosis | Men | Fibrosis | Classification | Informed consent | Lesions | Cholangiocarcinoma | Tumors | Index Medicus
Journal Article
Journal of Hepatology, ISSN 0168-8278, 10/2017, Volume 67, Issue 4, pp. 749 - 757
Journal Article
Hepatology, ISSN 0270-9139, 07/2018, Volume 68, Issue 1, pp. 113 - 126
Journal Article